Brief: Codex DNA Announces Commercial Availability Of Automated mRNA Synthesis Kit With Integrated Capping Technology For Bioxp™ System
29/11/2021 13:32
Nov 29 (Reuters) - Codex DNA Inc DNAY.O :
* CODEX DNA ANNOUNCES COMMERCIAL AVAILABILITY OF AUTOMATED
MRNA
SYNTHESIS KIT WITH INTEGRATED CAPPING TECHNOLOGY FOR BIOXP™
SYSTEM
Source text for Eikon: ID:nGNX6hXxS9
Further company coverage: DNAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telesis Bio
See all newsBrief: Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
Brief: Telesis Bio Plans To Delist Its Securities From The Nasdaq Stock Market
Brief: Telesis Bio Says Co Entered Share Purchase Agreement With Yuan Yang To Sell All Of Outstanding Capital Stock Of Eton Bio
Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary
Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview